Sohn, M., Talbert, J., Blumenschein, K., & Moga, D. C. (2015). Atypical antipsychotic initiation and the risk of type II diabetes in children and adolescents. Pharmacoepidemiology & Drug Safety, 24(6), 583. https://doi.org/10.1002/pds.3768
Chicago Style (17th ed.) CitationSohn, Minji, Jeffery Talbert, Karen Blumenschein, and Daniela Claudia Moga. "Atypical Antipsychotic Initiation and the Risk of Type II Diabetes in Children and Adolescents." Pharmacoepidemiology & Drug Safety 24, no. 6 (2015): 583. https://doi.org/10.1002/pds.3768.
MLA (9th ed.) CitationSohn, Minji, et al. "Atypical Antipsychotic Initiation and the Risk of Type II Diabetes in Children and Adolescents." Pharmacoepidemiology & Drug Safety, vol. 24, no. 6, 2015, p. 583, https://doi.org/10.1002/pds.3768.